Medscape Medical NewsAll articles

inHEART Models

inHEART, SAS • Radiology • 02/29/2024

510(k)IEC 62304 Class C
FDA Summary PDF

Device Purpose

inHEART MODELS is a medical imaging software suite designed to assist qualified medical professionals in cardiac treatment planning by processing CT and MR images to generate interactive 3D anatomical models. The system employs a combination of AI-driven automated segmentation for adult CT images (utilizing a UNet machine learning algorithm trained on 796 cases), along with manual and semi-automated tools for model generation, visualization, analysis, and annotation to support clinical decision-making.

Summary

inHEART MODELS is a comprehensive suite of medical imaging software tools designed to assist qualified medical professionals, including physicians, cardiologists, radiologists, and technicians, in the reading, interpretation, reporting, and treatment planning for cardiac conditions. The system processes DICOM-compliant medical images from CT and MR scanners to generate detailed 3D models of patient anatomy. It comprises three main software components: inHEART MODELS AI, which uses a machine-learning (UNet) based approach for automatic 3D modeling and pre-processing of adult CT images; inHEART MODELS Shaper, a standalone software for generating digital 3D heart models from CT and/or MR images through manual and semi-automated processing; and inHEART MODELS Explorer, a web-based platform for displaying, reviewing, analyzing, annotating, and exporting these 3D cardiac models. The AI module was trained on 796 anonymized CT cases from US and European institutions, employing data augmentation, regularization methods, specific loss functions, and optimization methods over 1000 epochs. The performance of the inHEART MODELS AI module, particularly its ability to provide initial segmentations for review and refinement, was validated using a separate dataset of 100 CT cases, ensuring independence from the training data. These AI-assisted segmentations, after expert review and editing using the inHEART MODELS Shaper, were compared against a ground truth established from expert-approved segmentations. The validation focused on metrics like Dice coefficient, Average Symmetric Surface Distance (ASSD), and volumetric differences for various cardiac structures including the aorta, left atrium, left ventricle endocardium and epicardium, pulmonary artery trunk, right atrium & inferior vena cava, and right ventricle endocardium and epicardium. Results for these revised AI-based segmentations demonstrated high accuracy, with an overall average Dice score of 0.94, an average ASSD of 1.17mm, and average volume variations of 9.18mL (7%), meeting predefined acceptance criteria and indicating the system's capability to produce accurate anatomical models to support therapeutic interventions.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Medical Imaging Software3D Cardiac ModelingTreatment PlanningDICOM ProcessingCT Image AnalysisMR Image AnalysisMachine LearningUNet AlgorithmAutomated SegmentationCardiac Visualization

Device Metadata

Submission Number
K231683
Company
inHEART, SAS
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. How does the performance of the inHEART MODELS AI module vary with different CT image qualities and across diverse patient populations not extensively represented in the initial 796-case training dataset?; What is the typical time saving and impact on inter-observer variability for cardiac structure segmentation when using the inHEART MODELS AI module followed by expert review, compared to fully manual or semi-automated methods?; Are there specific complex cardiac anatomies or post-intervention scenarios where the inHEART MODELS AI requires significantly more manual correction by expert users, and what is the learning curve for users to efficiently refine these AI-generated segmentations?; How does the web-based inHEART MODELS Explorer facilitate collaborative review and annotation of 3D cardiac models among multidisciplinary teams, and what are its data security features for handling sensitive patient information?; What are the plans to expand the training dataset for the inHEART MODELS AI to improve its robustness, and are there ongoing efforts to validate its utility for MR images or for pediatric patients, given its current indication for adult CT images only?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Post-§524B but no clear network capability detected

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score70/100
SBOM Evidence✓ Detected in Summary
Cyber Risk Assessment✓ Detected in Summary
Postmarket Plan⚠ Not in summary - likely in full submission per §524B
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials(software component)
✓ Detected
ML-BOMMachine Learning Bill of Materials(training data, machine learning, algorithm, dataset, ground truth)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(server, platform)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials(symmetric)
✓ Detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of SBOM, ML-BOM, SaaSBOM, CBOM detected in AI-generated device summary.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: HBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
inHEART Models - inHEART, SAS | ESL FDA AI Device Intelligence